Depression, Postpartum
Neurology
1
Pipeline Programs
2
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BiogenSAGE-217
BiogenZuranolone
BiogenZuranolone
NeuroneticsNeuroStar Transcranial Magnetic Stimulation
Clinical Trials (4)
Total enrollment: 444 patients across 4 trials
A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)
Start: Jun 2020Est. completion: Apr 2022200 patients
Phase 3Completed
Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)
Start: Apr 2023Est. completion: Oct 202419 patients
Phase 1Completed
A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy
Start: Jun 2025Est. completion: Aug 2026200 patients
N/ARecruiting
Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset
Start: Dec 2013Est. completion: Aug 201525 patients
N/ATerminated
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
11h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
11h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
11h ago
Director of Finance
CoMind
London, UK
11h ago
Electronics Engineering Manager
CoMind
London, UK
11h ago
Director of Information Technology
Zavation Medical Products
11h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 444 patients
2 companies competing in this space